James Investment Research’s NCI, Inc. NCIT Stock Holding History

James Investment Research’s Portfolio NCIT Stock Details NCIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-137,005	Closed	-$2.89M	–	835
2017 Q2	$2.89M	Sell	137,005 -540	-0.4%	-$9.27K	0.09%	165
2017 Q1	$2.07M	Hold	137,545	–	–	0.06%	212
2016 Q4	$1.92M	Hold	137,545	–	–	0.05%	222
2016 Q3	$1.59M	Hold	137,545	–	–	0.04%	213
2016 Q2	$1.93M	Hold	137,545	–	–	0.05%	203
2016 Q1	$1.93M	Hold	137,545	–	–	0.05%	191
2015 Q4	$1.88M	Buy	137,545 +26,995	+24%	+$402K	0.05%	187
2015 Q3	$1.47M	Hold	110,550	–	–	0.04%	190
2015 Q2	$1.14M	Buy	110,550 +1,500	+1%	+$15.7K	0.03%	222
2015 Q1	$1.13M	Buy	109,050 +1,970	+2%	+$22.3K	0.03%	232
2014 Q4	$1.09M	Buy	107,080 +4,460	+4%	+$47K	0.03%	227
2014 Q3	$976K	Sell	102,620 -190	-0.2%	-$1.78K	0.03%	228
2014 Q2	$913K	Buy	102,810 +32,230	+46%	+$312K	0.03%	224
2014 Q1	$750K	Buy	+70,580	New	+$653K	0.02%	251

James Investment Research's NCIT Position: Q3 2017 in Review

James Investment Research sold out of NCI, Inc. (NCIT) in Q3 2017, closing a stake of 137,005 shares — an estimated $2.89M sold.

James Investment Research first reported a position in NCIT in Q1 2014 and held it in 14 quarters. The position peaked at $2.89M in Q2 2017. 0 funds tracked by Wall St. Rank hold NCIT as of Q3 2017.

James Investment Research reported no remaining NCI, Inc. position as of Q3 2017 after selling out during the quarter.
James Investment Research sold 137,005 NCI, Inc. shares in Q3 2017, an estimated $2.89M.
James Investment Research first reported a position in NCI, Inc. in Q1 2014 and held it in 14 quarters.
James Investment Research's NCI, Inc. position peaked at $2.89M in Q2 2017.
0 funds tracked by Wall St. Rank held NCI, Inc. as of Q3 2017.

Based on James Investment Research's 13F filing for Q3 2017, filed 13 Oct 2017.